10.45
전일 마감가:
$10.28
열려 있는:
$10.3
하루 거래량:
71,649
Relative Volume:
0.08
시가총액:
$9.63M
수익:
$4.03M
순이익/손실:
$24.32M
주가수익비율:
-2.4298
EPS:
-4.3008
순현금흐름:
$-45.76M
1주 성능:
-3.24%
1개월 성능:
+26.06%
6개월 성능:
-24.28%
1년 성능:
-47.14%
Pavmed Inc Stock (PAVM) Company Profile
명칭
Pavmed Inc
전화
(212) 949-4319
주소
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PAVM
Pavmed Inc
|
10.45 | 9.47M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 개시 | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 개시 | Maxim Group | Buy |
Pavmed Inc 주식(PAVM)의 최신 뉴스
Can PAVmed Inc. sustain its profitabilityTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Signal Recap: Will PAVmed Inc stock hit new highs in YEARInsider Buying & Real-Time Volume Triggers - baoquankhu1.vn
Aug Sectors: Is PAVmed Inc a potential multi baggerWeekly Gains Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
PAVmed Restructures Capital With New Preferred Financing - TipRanks
PAVmed Signs Multiple Financing Agreements - TradingView
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
PAVmed Inc. announced that it expects to receive $30 million in funding - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Technical Analysis: Is PAVmed Inc a stock for growth or value investorsMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn
Is PAVmed Inc. stock a value trapJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - mfd.ru
What makes PAVmed Inc. stock attractive todayM&A Rumor & Consistent Profit Trading Strategies - mfd.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
PAVmed Regains Compliance with Nasdaq Minimum Bid Price - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Crypto: PAVM at Critical Level: Why This Week Matters - InteractiveCrypto
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates - Benzinga
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Dow Surges 300 Points; Netflix Shares Fall After Q4 Results - Benzinga
PAVmed Shares Soar Amid Strategic Developments and Market Reactions - timothysykes.com
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com Canada
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
PAVmed Inc. stock rises amid technical breakout - Intellectia AI
Lucid Diagnostics secures VA contract for esophageal cancer test - Investing.com
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® – Company Announcement - Financial Times
PAVMED announces 1-for-30 reverse stock split - MSN
Trade Recap: Is PAVmed Incs ROE strong enoughJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Can PAVmed Inc. stock deliver consistent earnings growthDividend Hike & Community Verified Trade Signals - bollywoodhelpline.com
S P Trends: Is PAVmed Inc stock a top performer YTDWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Aug Patterns: Can Ciena Corporation withstand a market correctionJuly 2025 Institutional & Stepwise Trade Signal Guides - baoquankhu1.vn
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
Bull Bear: Will PAVmed Inc stock hit new highs in YEAR2025 Institutional Moves & Verified Entry Point Detection - baoquankhu1.vn
Movement Recap: Can PAVmed Inc stock deliver 10 annual returns2025 EndofYear Setup & Verified Swing Trading Watchlists - Bộ Nội Vụ
Pavmed Inc (PAVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):